Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The study of immunological markers in tuberculosis across animal models and its translation to human research.

Lab animal·2026
Same author

NK cell-macrophage interactions in granulomas correlate with limited tuberculosis pathology.

PLoS pathogens·2025
Same author

Boosting Vaccine Research: The 16-Year Journey of TRANSVAC Vaccine Infrastructure.

Vaccines·2025
Same author

<i>Mtb</i>-Specific HLA-E-Restricted T Cells Are Induced during <i>Mtb</i> Infection but Not after BCG Administration in Non-Human Primates and Humans.

Vaccines·2024
Same author

<i>Mtb</i> specific HLA-E restricted T cells are induced during <i>Mtb</i> infection but not after BCG administration in non-human primates and humans.

bioRxiv : the preprint server for biology·2024
Same author

Potential business model for a European vaccine R&D infrastructure and its estimated socio-economic impact.

F1000Research·2024

Related Experiment Video

Updated: May 23, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Creativity in tuberculosis research and discovery.

Douglas Younga1, Frank A W Verreck

  • 1Division of Mycobacterial Research, MRC National Institute for Medical Research, London, UK. d.young@imperial.ac.uk

Tuberculosis (Edinburgh, Scotland)
|March 24, 2012
PubMed
Summary

Advances in tuberculosis (TB) vaccinology are progressing, with new vaccine candidates entering clinical trials. Future success requires combining empirical data with a deeper understanding of immune responses and improved translational research for next-generation TB vaccines.

More Related Videos

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
10:06

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

Published on: February 26, 2018

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Related Experiment Videos

Last Updated: May 23, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
10:06

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

Published on: February 26, 2018

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Area of Science:

  • Tuberculosis vaccinology
  • Immunology
  • Clinical trial development

Background:

  • Significant progress in tuberculosis (TB) vaccinology over the past decade.
  • Development driven by pragmatic progression of candidates through pipelines, supported by animal model protection data.
  • Efficacy data from Phase IIb trials for first-generation TB vaccine candidates are expected within 1-2 years.

Purpose of the Study:

  • To complement the empirical approach in TB vaccine development with fundamental research.
  • To inspire the design of next-generation TB vaccine candidates.
  • To leverage anticipated Phase IIb trial data effectively.

Main Methods:

  • Analysis of current trends in TB vaccinology.
  • Focus on empirical data from animal models and early-phase clinical trials.
  • Emphasis on integrating experimental and computational approaches to study biological complexity.

Main Results:

  • Encouraging protection data in animal models has fueled TB vaccine candidate development.
  • Anticipation of crucial efficacy data from Phase IIb trials in the near future.
  • Growing importance of understanding fundamental immune mechanisms and translational modalities.

Conclusions:

  • The empirical approach in TB vaccinology must be augmented by fundamental research.
  • Improved understanding of immune mechanisms and translational science are critical for next-generation TB vaccines.
  • Advanced experimental and computational methods are key to addressing biological complexity in TB vaccinology.